Agenda

  1. Homepage
  2. Agenda

Section VI:Probiotics,Prebiotics and Postbiotics——Probiotics Session 2:Probiotics and Prebiotics:Supporting whole life-cycle health 2.0

2026-03-13 13:00-15:45 BFA,Main Hall1/2-A,Level 2

Moderator:Zhang Jinjing ，Former Inspector of the Special Food Division,former National Market Supervision Administration
Supported by：Novonesis

2026-03-13 13:00-13:10

Opening Speech

Zhang Jinjing,Former Inspector of the Special Food Division,former National Market Supervision Administration
2026-03-13 13:10-13:35

Translating Chinese Human Milk Insights into HMO Applications in Early Life Nutrition

Yumei Zhang FULL Professor,School of Public Health,PEKING UNIVERSITY
2026-03-13 13:35-14:00

Fresh Raw Materials Empower a New Era of Whole-Lifecycle Nutrition

Zhang Xuguang Senior Engineer,Heilongjiang Feihe Dairy Co.,Ltd.Vice President、Director of the Research Institute
2026-03-13 14:00-14:25

Impact of Gut Microbiota and Bioactive Factors During Pregnancy on Maternal and Infant Health

Huixia Wang Chief Physician / Professor,Director,Department of Obstetrics and Gynecology,Peking University First Hospital;Associate Director,Department of Obstetrics and Gynecology,Peking University
2026-03-13 14:25-14:50

Unlocking longevity - exploring the microbiome's role in healthy aging

Mikkel Jungersen,Novonesis， Human Health Biosolutions Head of Clinical Development,Director
2026-03-13 14:50-15:00

Summary

Zhang Jinjing,Former Inspector of the Special Food Division,former National Market Supervision Administration
2026-03-13 15:00-15:45

Roundtable Meeting

Moderator: Zhang Jinjing ，Former Inspector of the Special Food Division,former National Market Supervision Administration
Panelist:
Huixia Wang Chief Physician / Professor，Director,Department of Obstetrics and Gynecology,Peking University First Hospital;Associate Director,Department of Obstetrics and Gynecology,Peking University；
Zhang Xuguang Senior Engineer，Heilongjiang Feihe Dairy Co.,Ltd.Vice President、Director of the Research Institute；
Yumei Zhang FULL Professor，School of Public Health,PEKING UNIVERSITY；
Li ling ， Head of Marketing,HHB APAC Novonesis；
hongwei Wang ，Novo Nordisk Asia-Pacific Medical Affairs and Science Director for Human Health。

Section VI:Probiotics,Prebiotics and Postbiotics——Probiotics Session 3:Synthetic Biology and Next-Generation Probiotic Development

2026-03-13 09:00-12:00 BFA,Main Hall1/2-A,Level 2

2026-03-13 09:00-09:05

Opening Speech

Zhu Jianguo Senior Principal Engineer,Wecare Probiotics Co.,Ltd
2026-03-13 09:05-09:25

Clinical Evidence:New Strategies to Drive Probiotic Viability and Efficacy Research

Fengqin Li Research Fellow,China National Center for Food Safety Risk Assessment
2026-03-13 09:25-09:45

Construction of an Ultrahigh-Throughput Microbial Screening Platform Based on Automation and Multidimensional Phenotyping:Industrial Application

Zheng Xiaowei ‌Professor-Level Senior Engineer‌,COFCO Nutrition and Health Research Institute Co.,Ltd
2026-03-13 09:45-10:00

The patented strain CCFM8631 empowers body management,from metabolic regulation mechanisms to clinical evidence

Sam Senior Engineer,Infinitus (China) Company Ltd，Frontier Technology Researcher
2026-03-13 10:00-10:15

From Concept to Gold Standard:Clinical Validation Reshaping the Core Competitiveness of Probiotic Products

Xu Yan Senior R&D Engineer,Wecare Probiotics Co.,Ltd
2026-03-13 10:15-10:35

From Mechanistic Exploration to Population Validation:Evidence-Based Medical Research on Seven-Strain Compound Probiotics and Their Functional Yogurt

He Fang Professor,West China School of Public health of Sichuan University (West China Fourth Hospital)
2026-03-13 10:35-10:55

Health Benefits of Probiotic Supplementation in Early Life:A Population-Based Real-World Study of 10,000 Subjects

Liu Feitong Senior Engineer,H&H Group,Senior Manager of Innovation Research
2026-03-13 10:55-11:10

From Research to Commerce:Health Solutions Targeting Gut Microbiota

Ou Ou,General Manager of Perfect Group Shanghai Weiyang Health Technology Co.,Ltd.
2026-03-13 11:10-11:30

Clinical Evidence-Based Research Progress of Highly Active Spore Probiotic BC99

Zhao Yunjiao Intermediate Engineer,Product Application Technology Director，Wecare Probiotics Co.,Ltd
2026-03-13 11:30-11:55

Launch of Highly Active Spore Probiotic BC99
2026-03-13 11:55-12:00

Application Launch of Highly Active Probiotic Products